Skip to content
Home
About Us
Management Team
Scientific Advisory Board
Board of Directors
Technology
Pipeline
Osteoporosis
Hypoparathyroidism
SBS & Obesity
Publications
Investors
Share Information
Share Chart
Email Alerts
Press Releases
SEC Filing
Investor Calendar
Corporate Governance
Board of Directors
Management
Committee Composition
Investor Resources
Investor FAQs
Document Request
Email Alerts
Corporate Presentation
Contact Us
Menu
Home
About Us
Management Team
Scientific Advisory Board
Board of Directors
Technology
Pipeline
Osteoporosis
Hypoparathyroidism
SBS & Obesity
Publications
Investors
Share Information
Share Chart
Email Alerts
Press Releases
SEC Filing
Investor Calendar
Corporate Governance
Board of Directors
Management
Committee Composition
Investor Resources
Investor FAQs
Document Request
Email Alerts
Corporate Presentation
Contact Us
SVB Securities Global Biopharma Conference
February 16, 2023
8:00 am
Publications
Click here for Webcast
READ MORE
September 25, 2024
EFFECTS OF EB613 TABLETS [ORAL PTH(1-34)] ON TRABECULAR AND CORTICAL BONE USING 3D-DXA: POST-HOC RESULTS FROM PHASE 2 STUDY Accepted for Oral Presentation at World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Read More »
August 20, 2024
Entera Bio to Participate in Upcoming Investor and Scientific Conferences – HCW, ASBMR, and Evercore
Read More »
August 20, 2024
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
Read More »
See all News
